Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
VYNT similar filings
- 26 Oct 21 Other Events
- 16 Aug 21 Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
- 17 May 21 Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
- 5 Apr 21 Report of Independent Registered Public Accounting Firm
- 25 Mar 21 Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
- 16 Mar 21 Other Events
- 26 Feb 21 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-252628, 333-239497, and 333-218229 on Form S-3, Registration Statement Nos. 333-191520, 333-191521, 333-196198, 333-205903, and 333-214599 on Form S-8, and Registration Statement No. 333-215284 on Form S-1 of Vyant Bio, Inc. of our report dated March 30, 2021, relating to the financial statements of StemoniX, Inc. appearing in this Current Report on Form 8-K dated April 5, 2021.
/s/ DELOITTE & TOUCHE LLP | |
Minneapolis, Minnesota | |
April 5, 2021 |